Shares of Abzena PLC (LON:ABZA) reached a new 52-week low on Friday . The company traded as low as GBX 30.50 ($0.40) and last traded at GBX 30.50 ($0.40), with a volume of shares traded.
A number of analysts have weighed in on the company. FinnCap reduced their target price on Abzena PLC from GBX 80 ($1.05) to GBX 70 ($0.92) and set a “buy” rating on the stock in a research note on Friday, September 22nd. Numis Securities Ltd reiterated a “buy” rating and issued a GBX 80 ($1.05) target price on shares of Abzena PLC in a research note on Thursday, September 14th.
TRADEMARK VIOLATION WARNING: “Abzena PLC (ABZA) Hits New 52-Week Low at $30.50” was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://sportsperspectives.com/2017/10/13/abzena-plc-abza-hits-new-52-week-low-at-30-50.html.
Abzena PLC Company Profile
Abzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups.
Receive News & Ratings for Abzena PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abzena PLC and related companies with MarketBeat.com's FREE daily email newsletter.